Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
As one of the leading causes for dementia in the population, it is imperative that we discern exactly why Alzheimer's disease (AD) has a strong molecular association with beta-amyloid and tau. Although a clear understanding about etiology and pathogenesis of AD remains unsolved, scientists worldwide have dedicated significant efforts to discovering the molecular interactions linked to the patholog...
In vivo imaging and accurate identification of amyloid-β (Aβ) plaque are crucial in Alzheimer's disease (AD) research. In this work, we propose to combine the coherent anti-Stokes Raman scattering (CARS) microscopy, a powerful detection technology for providing Raman spectra and label-free imaging, with deep learning to distinguish Aβ from non-Aβ regions in AD mice brains in vivo. The 1D CARS spec...
Background PET can be used for amyloid-tau-neurodegeneration (ATN) classification in Alzheimer disease, but incurs considerable cost and exposure to i...
OBJECTIVES: To evaluate caregiver opinions on the use of artificial intelligence (AI)-assisted medical decision-making for children with a respiratory...
Low pathogenicity avian influenza (LPAI) H7N3 was diagnosed in a flock of commercially raised Japanese quail () breeder hens. The birds were submitted...
OBJECTIVE: This study aimed to define a method of classifying patients with mild cognitive impairment caused by Alzheimer's disease by the retrieval o...
Early detection of individuals with a high risk of dementia is crucial for prompt intervention and clinical care. This study aims to identify high-ris...
Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) are considered an increasing major health problem in elderlies. However, current clinical...
We introduce an explainable deep neural architecture that combines brain structure with genetic influence to improve disease severity prediction in Al...
MOTIVATION: Alzheimer's disease (AD) is a neurodegenerative disease that affects millions of people worldwide. Mild cognitive impairment (MCI) is an i...
We applied natural language processing and topic modeling to publicly available abstracts and titles of 263 papers in the scientific literature mentio...
Alzheimer's disease (AD) is one of the most challenging neurodegenerative diseases because of its complicated and progressive mechanisms, and multiple...
This study aimed to analyse cerebral grey matter changes in mild cognitive impairment (MCI) using voxel-based morphometry and to diagnose early Alzhei...
In life science and medicine, we have been conducting research using laboratory animals such as mice, rats and monkeys. However, it is impossible for ...
Social robot pets promote engagement and psychosocial well-being among older adults, yet little is known about their use among community-dwelling Vete...
Contemporary medical research increasingly focuses on the blood-brain barrier (BBB) to maintain homeostasis in healthy individuals and provide solutio...
BACKGROUND: the Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) dementia risk score is a recognised tool for dementia risk strat...
BACKGROUND: Persons living with dementia and their care partners place a high value on aging in place and maintaining independence. Socially assistive...
Translating human genetic findings (genome-wide association studies [GWAS]) to pathobiology and therapeutic discovery remains a major challenge for Al...
OBJECTIVE: Alzheimer's disease (AD) is the most common neurodegenerative disorder with one of the most complex pathogeneses, making effective and clin...